From: Stentless aortic valve replacement in the young patient: long-term results
Procedure | Number | Percent |
---|---|---|
Isolated SAVR | 128 | 68.1% |
SAVR + other | 60 | 31.9% |
AscAo | 21 | 11.2% |
MVR | 16 | 8.5% |
CABG | 13 | 6.9% |
CABG + other | 5 | 2.6% |
Myectomie | 3 | 1.6% |
Closure of VSD | 1 | 0.5% |
Passive Cardiomyoplasty* | 1 | 0.5% |
Surgical approach | ||
Median sternotomy | 182 | 96.8% |
Upper ministernotomy | 6 | 3.2% |
Implanted valves | ||
Edwards Prima-Plus® | 120 | 63.8% |
SJM Toronto-SPV® | 50 | 26.6% |
Medtronik FreeStyle® | 10 | 5.3% |
Vascutec Elan® | 7 | 3.7% |
Shelhigh-stentless® | 1 | 0.5% |
Implanted valve sizes | ||
23 mm | 3 | 1.6% |
25 mm | 35 | 18.6% |
27 mm | 79 | 42.0% |
29 mm | 71 | 37.8% |